Table 2. Characteristics of patients in each ablation strategy.
Trails | No of Patients | Age (y) | Male (%) | PAF (%) | LVEF (%) | LA Diameter (mm) | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
E | C | E | C | E | C | E | C | E | C | E | C | |
Adjunctive GP Ablation Strategy | ||||||||||||
Scherlag 2005 | 33 | 27 | — | — | — | — | 51 | 52 | — | — | — | — |
Pokushalov 2013 | 132 | 132 | 55±6 | 54±7 | 76 | 79 | 0 | 0 | 55.1±4.8 | 54.2±6.3 | 49±7 | 48±7 |
Katritsis 2011 | 34 | 33 | 55.2±11.6 | 53.2±11.3 | 73 | 79 | 100 | 100 | 56.2±7.7 | 56.1±5.3 | 41.5±5.4 | 41.1±3.3 |
Katritsis 2013 | 82 | 78 | 56±8.5 | 56±7.6 | 69 | 68 | 100 | 100 | 62±8.1 | 63±6.8 | 48±6 | 48±7 |
Adjunctive CFAE Ablation Strategy | ||||||||||||
Verma 2015 | 244 | 61 | 58±10 | 60±9 | 52 | 213 | 0 | 0 | 57±10 | 55±11 | 44±6 | 44±6 |
Vogler 2015 | 71 | 61 | 61.1± 10.9 | 63.0± 9.6 | 60 | 56 | 0 | 0 | 59.8 ± 7.1 | 60.0 ± 7.1 | 43.7± 5.2 | 44.5 ± 6.6 |
Oral 2009 | 50 | 50 | 62±8 | 58±10 | 82 | 82 | 0 | 0 | 54±9 | 53±12 | 46±6 | 47±6 |
Verma 2008 | 35 | 35 | 61±9 | 60±11 | 74 | 77 | 60 | 60 | 53±7 | 53±8 | 43±9 | 41±10 |
Lin 2009 | 30 | 30 | 49±10 | 49±12 | 80 | 87 | 0 | 0 | 54±8 | 56±8 | 41±7.6 | 40±4.7 |
Chen 2011 | 58 | 35 | 56.4±11.2 | 52.2±13.2 | 67 | 71 | 100 | 100 | 64.5±3.3 | 66.2±4.1 | 34.2±3.6 | 34.7±4.2 |
Baise 2009 | 34 | 35 | 58.4±7.5 | 57±8.1 | 88 | 83 | 100 | 100 | 54.6±6 | 55±8 | 44±6 | 43±6 |
Elayi 2008 | 49 | 48 | 59.2±11.5 | 58.1±10.3 | 65 | 69 | 0 | 0 | 55 | 52 | 46.2±6.4 | 45.1±6.6 |
Verma 2010 | 34 | 32 | 59±10 | 55±11 | 74 | 75 | 65 | 66 | 59±12 | 62±7 | 41±6 | 43±5 |
Nam 2012 | 35 | 35 | 54±11 | 55±11 | 86 | 86 | 100 | 100 | 59±6 | 61±5 | 40±5.1 | 40±4.5 |
E, experiment group (GP+PVI); C, control group (PVI); PAF, paroxysmal AF; LVEF, left ventricular ejection fraction; LA, left atria.